{"text": ["Nektar", "(NKTR)", "Q2", "Earnings", "Beat", "Estimates,", "Revenues", "Miss"], "created_at": "2019-08-09 17:13:06"}
{"text": ["Nektar", "(NKTR)", "Q2", "Earnings", "Beat", "Estimates,", "Revenues", "Miss"], "created_at": "2019-08-09 17:13:06"}
{"text": ["Intrexon", "(XON)", "Reports", "Narrower-Than-Expected", "Loss", "in", "Q2"], "created_at": "2019-08-09 17:12:41"}
{"text": ["Intrexon", "(XON)", "Reports", "Narrower-Than-Expected", "Loss", "in", "Q2"], "created_at": "2019-08-09 17:12:41"}
{"text": ["U.S.", "Court", "of", "Appeals", "Rules", "in", "Favor", "of", "Lilly", "in", "Alimta", "Alternate", "Salt", "Form", "Patent", "Lawsuit"], "created_at": "2019-08-09 16:17:00"}
{"text": ["Pharma", "Stock", "Roundup:", "AGN,", "NVO", "Earnings,", "EU", "Nod", "to", "SNY", "&", "ABBV", "Drugs", "for", "New", "Patients"], "created_at": "2019-08-09 16:15:55"}
{"text": ["Pharma", "Stock", "Roundup:", "AGN,", "NVO", "Earnings,", "EU", "Nod", "to", "SNY", "&", "ABBV", "Drugs", "for", "New", "Patients"], "created_at": "2019-08-09 16:15:55"}
{"text": ["Novo", "Nordisk", "(NVO)", "Q2", "Earnings", "&", "Revenues", "Beat", "Estimates"], "created_at": "2019-08-09 15:18:06"}
{"text": ["Novo", "Nordisk", "(NVO)", "Q2", "Earnings", "&", "Revenues", "Beat", "Estimates"], "created_at": "2019-08-09 15:18:06"}
{"text": ["Nektar", "(NKTR)", "Q2", "Earnings", "Beat", "Estimates,", "Revenues", "Miss"], "created_at": "2019-08-09 15:11:53"}
{"text": ["Intrexon", "(XON)", "Reports", "Narrower-Than-Expected", "Loss", "in", "Q2"], "created_at": "2019-08-09 14:59:02"}
{"text": ["Pharma", "Stock", "Roundup:", "AGN,", "NVO", "Earnings,", "EU", "Nod", "to", "SNY", "&", "ABBV", "Drugs", "for", "New", "Patients"], "created_at": "2019-08-09 13:50:01"}
{"text": ["Novo", "Nordisk", "(NVO)", "Q2", "Earnings", "&", "Revenues", "Beat", "Estimates"], "created_at": "2019-08-09 13:27:01"}
